Proxy Votes Now

Home › Funds › Equitable › EQ/Morgan Stanley Small Cap Growth Portfolio

EQ/Morgan Stanley Small Cap Growth Portfolio proxy voting record 2025-2026

Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000044689

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 8,555 with, 39 against, 2 abstentions (not counted as with management); 1 items carried no recommendation; 4 split votes are in neither count. Shareholder proposals: 3 FOR, 15 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Equitable as a whole

The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEquitableItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)94.5%8,28192.5%339,726
Backed environmental and social shareholder proposals at US companiesn/a49.6%3,486

Where this fund voted differently from most Equitable funds

Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Equitable funds on 208 items (2.6% of the 8,100 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Roivant Sciences Ltd.2025-09-10To cast a non-binding, advisory vote to approve the compensation of our named executive officers.ForAGAINST — 8 of 8 Equitable fundsForApproved, 60.9% support
Appian Corporation2026-06-03Election of Directors: Barbara Bobbie KilbergForWITHHOLD — 7 of 7 Equitable fundsAgainstElected, 96.2% support
Appian Corporation2026-06-03To approve the Appian Corporation Amended and Restated 2017 Equity Incentive Plan.ForAGAINST — 7 of 7 Equitable fundsAgainstApproved, 94.2% support
Burford Capital Ltd.2026-05-13To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement for the 2026 annual general meeting of shareholders under "Executive compensation", including the compensation discussion and analysis, the compensation tables and the relForAGAINST — 7 of 7 Equitable fundsAgainst—
Cloudflare, Inc.2026-06-30Approval and adoption of an amendment and restatement of our amended and restated certificate of incorporation: Approval and adoption of amendments to establish the Class C common stock.ForAGAINST — 6 of 6 Equitable fundsFor—
Cloudflare, Inc.2026-06-30Approval of one or more adjournments of the meeting, if necessary to solicit additional proxies in favor of the proposals presented at the meeting.ForAGAINST — 6 of 6 Equitable fundsForApproved, 66.2% support
Cloudflare, Inc.2026-06-30Approval of the amendment and restatement of our 2019 Equity Incentive Plan.ForAGAINST — 6 of 6 Equitable fundsForApproved, 63.1% support
Cloudflare, Inc.2026-06-30Approval of the amendment and restatement of our Amended and Restated 2019 Employee Stock Purchase Plan.ForAGAINST — 6 of 6 Equitable fundsForApproved, 71.6% support
Burford Capital Ltd.2026-05-13To re-elect John Sievwright as director.ForAGAINST — 6 of 6 Equitable fundsAgainstPassed (calculated), 84.8% support
Semler Scientific, Inc.2025-09-05To approve the amendment of Semler Scientific, Inc.'s Restated Certificate of Incorporation, as amended to increase the total number of shares of our common stock authorized for issuance from 50,000,000 shares to 210,000,000 shares.ForAGAINST — 6 of 6 Equitable fundsAgainstApproved, 75.8% support
Semler Scientific, Inc.2025-09-05To approve the amendment of the Restated Certificate of Incorporation, as amended, to authorize the issuance of 42,000,000 shares of "blank-check" preferred stock.ForAGAINST — 6 of 6 Equitable fundsAgainstNot approved, 64.3% support
Semler Scientific, Inc.2025-09-05To elect the following nominee to Class I of our board of directors: William H.C. ChangForWITHHOLD — 6 of 6 Equitable fundsAgainstElected, 96.3% support
Aurora Innovation, Inc.2026-05-21Election of Directors: Michelangelo VolpiForWITHHOLD — 5 of 5 Equitable fundsForElected, 98.4% support
agilon health, inc.2026-06-02Election of Class II Directors: Ronald WilliamsForAGAINST — 5 of 5 Equitable fundsAgainstElected, 91.4% support
Cloudflare, Inc.2026-06-30Approval and adoption of amendments to implement a stock split in which (i) each share of Class A common stock would become one share of Class A common stock and one share of Class C common stock; and (ii) each share of Class B common stock would become one share of Class B common stock and one sharForAGAINST — 6 of 7 Equitable fundsFor—
Cloudflare, Inc.2026-06-30Approval and adoption of amendments to increase the number of authorized shares of Class A common stock from 2,250,000,000 to 4,500,000,000.ForAGAINST — 6 of 7 Equitable fundsForApproved, 66.7% support
Cloudflare, Inc.2026-06-30Approval and adoption of amendments to increase the number of authorized shares of preferred stock from 225,000,000 to 450,000,000.ForAGAINST — 6 of 7 Equitable fundsForApproved, 66.3% support
Cloudflare, Inc.2026-06-30Approval and adoption of amendments to provide for the equal treatment of shares of Class A common stock, Class B common stock, and Class C common stock in connection with dividends and distributions, certain transactions, and upon our liquidation, dissolution, or winding up.ForAGAINST — 6 of 7 Equitable fundsForApproved, 66.7% support
Cloudflare, Inc.2026-06-30Approval and adoption of amendments to require the approval of a majority of the independent directors then in office for any acquisition in which we would issue shares of Class C common stock as consideration for such acquisition with a fair market value in excess of $100,000,000.ForAGAINST — 6 of 7 Equitable fundsForApproved, 66.8% support
Cloudflare, Inc.2026-06-30Approval, on an advisory basis, of the compensation of our named executive officers.ForAGAINST — 6 of 7 Equitable fundsForApproved, 76.2% support
Cloudflare, Inc.2026-06-302 wordings Election of Class I directors: Scott SandellForWITHHOLD — 5 of 6 Equitable fundsForElected, 90.3% support
Aurora Innovation, Inc.2026-05-21Election of Directors: Gloria BoylandForWITHHOLD — 4 of 5 Equitable fundsForElected, 97.3% support
Arbutus Biopharma Corporation2026-05-26To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Matthew GlineForWITHHOLD — 4 of 5 Equitable fundsAgainstPassed (calculated), 86.5% support
Semler Scientific, Inc.2026-01-13To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to the named executive officers of Semler Scientific that arises from or otherwise relates to the Merger.ForAGAINST — 4 of 5 Equitable fundsAgainstApproved, 62.3% support
BrightSpring Health Services, Inc.2026-05-21Election of Class II directors: Max LinWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 76.3% support
Show all 208
Items 26 to 208.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Madrigal Pharmaceuticals, Inc.2026-06-172 wordings Re-election of Class I directors: Julian BakerForWITHHOLD — 5 of 8 Equitable fundsForElected, 88.6% support
FirstCash Holdings, Inc.2026-06-09Approve the reincorporation of the Company to the State of Texas by conversion.ForAGAINST — 5 of 8 Equitable fundsForApproved, 58.4% support
FirstCash Holdings, Inc.2026-06-09Election of Directors: Randel G. OwenForAGAINST — 5 of 8 Equitable fundsForPassed (calculated), 87.7% support
Etsy, Inc.2026-06-09Approval of an amendment to our 2024 Equity Incentive Plan to increase the number of shares of our common stock available for issuance.ForAGAINST — 5 of 8 Equitable fundsForApproved, 60.2% support
Rambus Inc.2026-04-23Election of Directors: Charles KissnerForAGAINST — 5 of 8 Equitable fundsForPassed (calculated), 85.5% support
Rambus Inc.2026-04-23Election of Directors: Luc SeraphinForAGAINST — 5 of 8 Equitable fundsForPassed (calculated), 98.5% support
Rambus Inc.2026-04-23Election of Directors: Meera RaoForAGAINST — 5 of 8 Equitable fundsForPassed (calculated), 93.9% support
Rambus Inc.2026-04-23Election of Directors: Necip SayinerForAGAINST — 5 of 8 Equitable fundsForPassed (calculated), 93.5% support
Silicon Laboratories Inc.2026-04-23To elect two Class I directors to serve on the Board of Directors until our 2029 annual meeting of stockholders, or until a successor is duly elected and qualified: Navdeep S. SoochForAGAINST — 5 of 8 Equitable fundsForPassed (calculated), 97.6% support
Silicon Laboratories Inc.2026-04-23To elect two Class I directors to serve on the Board of Directors until our 2029 annual meeting of stockholders, or until a successor is duly elected and qualified: Nina RichardsonForAGAINST — 5 of 8 Equitable fundsForPassed (calculated), 98.5% support
Rhythm Pharmaceuticals, Inc.2026-06-24Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirrForWITHHOLD — 5 of 8 Equitable fundsForPassed (calculated), 85.9% support
Qualys, Inc.2026-06-10Election of Directors: John A. ZangardiForWITHHOLD — 5 of 8 Equitable fundsForElected, 94.5% support
Qualys, Inc.2026-06-10Election of Directors: Wendy M. PfeifferForWITHHOLD — 5 of 8 Equitable fundsForElected, 91.4% support
Cloudflare, Inc.2026-06-30Election of Class I directors: Michelle ZatlynForWITHHOLD — 4 of 6 Equitable fundsForElected, 97.0% support
Bloom Energy Corporation2026-05-21Election of our four Class II Directors: Eddy ZervigonForWITHHOLD — 4 of 6 Equitable fundsForElected, 76.8% support
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. ChouForWITHHOLD — 4 of 6 Equitable fundsForElected, 71.3% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Daniel HumeForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 78.6% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Yann EchelardForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 78.7% support
Protagonist Therapeutics, Inc.2026-06-17To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lewis T. "Rusty" Williams, M.D., Ph.D.ForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 80.2% support
Arrowhead Pharmaceuticals, Inc.2026-03-19Election of Directors: Michael S. PerryAgainstFOR — 4 of 6 Equitable fundsAgainst—
Zeta Global Holdings Corp.2026-06-16Election of Directors: Jeanine SilberblattForWITHHOLD — 4 of 6 Equitable fundsForElected, 90.0% support
Zeta Global Holdings Corp.2026-06-16Election of Directors: Robert NiehausForWITHHOLD — 4 of 6 Equitable fundsForElected, 97.1% support
Zeta Global Holdings Corp.2026-06-16Election of Directors: William LandmanForWITHHOLD — 4 of 6 Equitable fundsForElected, 93.7% support
Axsome Therapeutics, Inc.2026-06-05Election of Directors: Mark SaadForWITHHOLD — 4 of 6 Equitable fundsForElected, 73.6% support
Axsome Therapeutics, Inc.2026-06-05Election of Directors: Susan Mahony, Ph.D., MBAForWITHHOLD — 4 of 6 Equitable fundsForElected, 76.7% support
Workiva Inc.2026-05-28Election of Directors: Michael M. Crow, Ph.D.ForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 77.9% support
Tenable Holdings, Inc.2026-05-13To elect the Board of Directors' nominees, John C. Huffard, Jr., A. Brooke Seawell, and Raymond Vicks, Jr., to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: A. Brooke SeawellForWITHHOLD — 4 of 6 Equitable fundsForElected, 74.7% support
Tenable Holdings, Inc.2026-05-13To elect the Board of Directors' nominees, John C. Huffard, Jr., A. Brooke Seawell, and Raymond Vicks, Jr., to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Raymond Vicks, Jr.ForWITHHOLD — 4 of 6 Equitable fundsForElected, 75.9% support
Appian Corporation2026-06-03Election of Directors: Carl Boe Hartman IIForWITHHOLD — 4 of 6 Equitable fundsForElected, 99.9% support
Appian Corporation2026-06-03Election of Directors: Mark LynchForWITHHOLD — 4 of 6 Equitable fundsForElected, 98.4% support
Appian Corporation2026-06-03Election of Directors: Matthew CalkinsForWITHHOLD — 4 of 6 Equitable fundsForElected, 98.2% support
Appian Corporation2026-06-03Election of Directors: Robert C. KramerForWITHHOLD — 4 of 6 Equitable fundsForElected, 98.3% support
Appian Corporation2026-06-03Election of Directors: Shirley A. EdwardsForWITHHOLD — 4 of 6 Equitable fundsForElected, 98.0% support
D-Wave Quantum Inc.2026-06-04Election of two Class I directors to hold office until our 2029 Annual Meeting of Stockholders: Sharon HoltForWITHHOLD — 4 of 6 Equitable fundsForPassed (calculated), 86.1% support
Intapp, Inc.2025-11-18To elect three Class II Directors, each to hold office until our Annual Meeting of Stockholders in 2028 and until her successor is duly elected and qualified: Beverly AllenForWITHHOLD — 4 of 6 Equitable fundsForElected, 81.0% support
Intapp, Inc.2025-11-18To elect three Class II Directors, each to hold office until our Annual Meeting of Stockholders in 2028 and until her successor is duly elected and qualified: Nancy HarrisForWITHHOLD — 4 of 6 Equitable fundsForElected, 95.2% support
Freshworks Inc.2026-05-28To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.ForAGAINST — 4 of 6 Equitable fundsForApproved, 86.9% support
Freshworks Inc.2026-05-28To elect the four nominees for Class II Directors, each to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Roxanne S. AustinForWITHHOLD — 4 of 6 Equitable fundsForElected, 91.3% support
Freshworks Inc.2026-05-28To elect the four nominees for Class II Directors, each to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Sameer GandhiForWITHHOLD — 4 of 6 Equitable fundsForElected, 93.1% support
SPS Commerce, Inc.2026-05-28Election of Directors: Michael McConnellForAGAINST — 4 of 6 Equitable fundsForElected, 78.6% support
Ambarella, Inc.2026-06-26Election of Directors: D. Jeffrey RichardsonForWITHHOLD — 4 of 6 Equitable fundsForElected, 89.0% support
Ambarella, Inc.2026-06-26Election of Directors: Elizabeth M. SchwartingForWITHHOLD — 4 of 6 Equitable fundsForElected, 80.4% support
Grindr Inc.2026-06-02Election of Directors: Daniel Brooks BaerForWITHHOLD — 4 of 6 Equitable fundsForElected, 84.8% support
Grindr Inc.2026-06-02Election of Directors: G. Raymond Zage, IIIForWITHHOLD — 4 of 6 Equitable fundsForElected, 88.2% support
SoundHound AI, Inc.2026-05-22Election of Directors: Diana SrokaForWITHHOLD — 4 of 6 Equitable fundsForElected, 97.2% support
SoundHound AI, Inc.2026-05-22Election of Directors: Larry MarcusForWITHHOLD — 4 of 6 Equitable fundsForElected, 96.2% support
Inspire Medical Systems, Inc.2026-04-30Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan.AgainstFOR — 3 of 4 Equitable fundsAgainstApproved, 62.0% support
C3.ai, Inc.2025-10-03Election of Class II Directors: General (Ret.) John HytenForWITHHOLD — 4 of 6 Equitable fundsForElected, 97.9% support
C3.ai, Inc.2025-10-03Election of Class II Directors: Richard C. LevinForWITHHOLD — 4 of 6 Equitable fundsForElected, 98.0% support
Alkami Technology, Inc.2026-05-19To elect the three nominees for director named herein to serve as Class II directors to hold office until the 2029 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: Brian R. SmithForWITHHOLD — 4 of 6 Equitable fundsForElected, 72.9% support
Ocular Therapeutix, Inc.2026-06-10To approve an advisory vote on named executive officer compensation.AgainstFOR — 4 of 6 Equitable fundsAgainst—
DigitalOcean Holdings, Inc.2026-06-15Election of Class II Directors: Warren AdelmanForWITHHOLD — 5 of 9 Equitable fundsForPassed (calculated), 79.8% support
Cytokinetics, Incorporated2026-05-273 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.ForWITHHOLD — 5 of 9 Equitable fundsForPassed (calculated), 97.0% support
GPGI, Inc.2026-06-11Election of Directors: Brian F. HughesWithholdFOR — 5 of 9 Equitable fundsAgainstPassed (calculated), 97.8% support
Roivant Sciences Ltd.2025-09-10To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith ManchesterForWITHHOLD — 4 of 7 Equitable fundsForElected, 70.6% support
Roivant Sciences Ltd.2025-09-10To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa EpperlyForWITHHOLD — 4 of 7 Equitable fundsForElected, 73.5% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Ian ClarkForWITHHOLD — 4 of 7 Equitable fundsForElected, 65.0% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Manuel Hidalgo MedinaForWITHHOLD — 4 of 7 Equitable fundsForElected, 75.5% support
Glaukos Corporation2026-05-28Election of Directors: Aimee S. WeisnerForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 95.0% support
Glaukos Corporation2026-05-28Election of Directors: Denice M. TorresForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 78.5% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: David A. DunbarForWITHHOLD — 4 of 7 Equitable fundsForElected, 90.0% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Joseph T. NoonanForWITHHOLD — 4 of 7 Equitable fundsForElected, 99.1% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Joseph W. ReitmeierForWITHHOLD — 4 of 7 Equitable fundsForElected, 90.1% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Kenneth NapolitanoForWITHHOLD — 4 of 7 Equitable fundsForElected, 90.3% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Merilee RainesForWITHHOLD — 4 of 7 Equitable fundsForElected, 89.9% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Michael J. DuboseForWITHHOLD — 4 of 7 Equitable fundsForElected, 86.1% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Rebecca J. BollForWITHHOLD — 4 of 7 Equitable fundsForElected, 90.3% support
Watts Water Technologies, Inc.2026-05-19Election of Directors: Robert J. Pagano, Jr.ForWITHHOLD — 4 of 7 Equitable fundsForElected, 97.9% support
10x Genomics, Inc.2026-06-04Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatioForAGAINST — 4 of 7 Equitable fundsForPassed (calculated), 86.6% support
Sanmina Corporation2026-03-09To elect eight directors of Sanmina Corporation: Mythili SankaranForAGAINST — 4 of 7 Equitable fundsForPassed (calculated), 56.9% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSciForWITHHOLD — 4 of 7 Equitable fundsForElected, 85.3% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William FaireyForWITHHOLD — 4 of 7 Equitable fundsForElected, 86.8% support
Dycom Industries Inc.2026-05-28Election of Directors: Peter T. Pruitt, Jr.ForAGAINST — 4 of 7 Equitable fundsForPassed (calculated), 96.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Andrea PerezForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 99.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Andrew DudumForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 99.1% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Anja ManuelForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 99.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Christopher PayneForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 99.4% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: David WellsForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 98.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Deb AutorForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 99.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Delos Cosgrove, M.D.ForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 99.9% support
Hims & Hers Health, Inc.2026-06-11Election of Directors: Kare SchultzForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 99.9% support
Calix, Inc.2026-05-14To elect each of the three director nominees named in the proxy statement: Kathleen CruscoForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 90.7% support
BioCryst Pharmaceuticals, Inc.2026-06-11To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan.ForAGAINST or ABSTAIN — 4 of 7 Equitable fundsForApproved, 65.4% support
Globalstar, Inc.2026-05-13Approve, on an advisory basis, the compensation of our named executive officers.ForAGAINST — 3 of 5 Equitable fundsForApproved, 96.4% support
Globalstar, Inc.2026-05-13Election of Class B Directors: Timothy E. TaylorForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 95.4% support
Twist Bioscience Corporation2026-02-05Election of Class II Directors: Jan JohannessenForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 84.1% support
Twist Bioscience Corporation2026-02-05Election of Class II Directors: Keith CrandellForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 80.5% support
Twist Bioscience Corporation2026-02-05To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."ForAGAINST — 3 of 5 Equitable fundsForApproved, 76.4% support
ESCO Technologies Inc.2026-01-30Election of Directors: Patrick M. DewarForWITHHOLD — 3 of 5 Equitable fundsForElected, 96.4% support
StoneX Group Inc.2026-03-10Election of Directors: Steven KassForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 97.2% support
Xometry, Inc.2026-06-16To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Fabio RosatiForWITHHOLD — 3 of 5 Equitable fundsForElected, 90.0% support
Xometry, Inc.2026-06-16To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Katharine WeymouthForWITHHOLD — 3 of 5 Equitable fundsForElected, 86.7% support
IES Holdings, Inc.2026-02-19ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.AgainstFOR — 3 of 5 Equitable fundsAgainstApproved, 92.8% support
IES Holdings, Inc.2026-02-19ELECTION OF DIRECTORS: TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING AND UNTIL THEIR SUCCESSORS ARE ELECTED AND QUALIFIED: JOE D. KOSHKINWithholdFOR — 3 of 5 Equitable fundsAgainstPassed (calculated), 96.6% support
IES Holdings, Inc.2026-02-19ELECTION OF DIRECTORS: TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING AND UNTIL THEIR SUCCESSORS ARE ELECTED AND QUALIFIED: TODD M. CLEVELANDWithholdFOR — 3 of 5 Equitable fundsAgainstPassed (calculated), 97.2% support
Braze, Inc.2026-06-302 wordings Election of Two Class II Directors, each to hold office until our 2029 Annual Meeting of Stockholders: Neeraj AgrawalForWITHHOLD — 3 of 5 Equitable fundsForElected, 78.6% support
StepStone Group Inc.2025-09-09To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Michael I. McCabeForWITHHOLD — 3 of 5 Equitable fundsForElected, 91.4% support
StepStone Group Inc.2025-09-09To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Monte M. BremWithholdFOR — 3 of 5 Equitable fundsAgainstElected, 85.9% support
StepStone Group Inc.2025-09-09To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Steven R. MitchellForWITHHOLD — 3 of 5 Equitable fundsForElected, 90.8% support
BGC Group, Inc.2025-11-12Approval, on an advisory basis, of executive compensation.ForAGAINST — 3 of 5 Equitable fundsForApproved, 93.6% support
BGC Group, Inc.2025-11-12Election of Directors: Arthur U. MbanefoForWITHHOLD — 3 of 5 Equitable fundsForElected, 92.5% support
BGC Group, Inc.2025-11-12Election of Directors: David P. RichardsForWITHHOLD — 3 of 5 Equitable fundsForElected, 94.5% support
BGC Group, Inc.2025-11-12Election of Directors: Linda A. BellForWITHHOLD — 3 of 5 Equitable fundsForElected, 94.2% support
BGC Group, Inc.2025-11-12Election of Directors: William D. AddasForWITHHOLD — 3 of 5 Equitable fundsForElected, 94.7% support
Modine Manufacturing Company2025-08-21Election of Directors: Mr. David J. WilsonForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 91.6% support
Acushnet Holdings Corp.2026-06-08Election of the following nominees for director: Yoon Soo (Gene) YoonWithholdFOR — 3 of 5 Equitable fundsAgainstElected, 82.6% support
Remitly Global, Inc.2026-06-10Election of Directors: Bora ChungForWITHHOLD — 3 of 5 Equitable fundsForElected, 96.0% support
Remitly Global, Inc.2026-06-10Election of Directors: Laurent Le MoalForWITHHOLD — 3 of 5 Equitable fundsForElected, 96.3% support
Remitly Global, Inc.2026-06-10Election of Directors: Nigel MorrisForWITHHOLD — 3 of 5 Equitable fundsForElected, 68.9% support
Moelis & Company2026-06-25Election of Directors: Eric CantorForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 97.8% support
Moelis & Company2026-06-25Election of Directors: Kenneth L. ShropshireForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 87.9% support
Moelis & Company2026-06-25Election of Directors: Kenneth MoelisForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 98.3% support
Moelis & Company2026-06-25Election of Directors: Laila J. WorrellForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 85.0% support
Moelis & Company2026-06-25Election of f Directors: Louise MirrerForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 84.0% support
Moelis & Company2026-06-25To approve, on an advisory basis, the compensation of our Named Executive Officers.ForAGAINST — 3 of 5 Equitable fundsForApproved, 76.5% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: Aylwin LewisAgainstFOR — 3 of 5 Equitable fundsAgainstPassed (calculated), 73.2% support
The Chefs' Warehouse, Inc.2026-05-08To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the 2026 Proxy Statement.AgainstFOR — 3 of 5 Equitable fundsAgainstApproved, 51.0% support
Construction Partners, Inc.2026-03-24Proposal to elect two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Craig JenningsForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 79.8% support
Interparfums, Inc.2025-09-10To vote for the advisory resolution to approve executive compensation.ForAGAINST — 3 of 5 Equitable fundsForApproved, 84.3% support
CorVel Corporation2025-08-07To approve the 2025 Stock Incentive Plan.ForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 84.0% support
CorVel Corporation2025-08-07To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Jeffrey J. MichaelWithholdFOR — 3 of 5 Equitable fundsAgainstPassed (calculated), 84.4% support
CorVel Corporation2025-08-07To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: R. Judd JessupWithholdFOR — 3 of 5 Equitable fundsAgainstPassed (calculated), 87.6% support
Edgewise Therapeutics, Inc.2026-06-04Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Badreddin Edris, Ph.D.WithholdFOR — 3 of 5 Equitable fundsAgainstElected, 70.3% support
Franklin Electric Co., Inc.2026-05-082 wordings Elect Victor D. Grizzle and Alok Maskara as directors for terms expiring at the 2029 Annual Meeting of Shareholders: Victor D. GrizzleForAGAINST — 3 of 5 Equitable fundsFor—
Boot Barn Holdings, Inc.2025-08-27Election of Directors: Lisa G. LaubeWithholdFOR — 3 of 5 Equitable fundsAgainstElected, 78.3% support
Acadia Pharmaceuticals Inc.2026-05-29To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Adora Ndu, Pharm.D., J.D.ForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 89.4% support
Acadia Pharmaceuticals Inc.2026-05-29To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. DalyForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 97.7% support
Madison Square Garden Entertainment Corp.2025-12-10Election of the following nominees as directors: Donna M. ColemanForWITHHOLD — 3 of 5 Equitable fundsForElected, 79.5% support
Madison Square Garden Entertainment Corp.2025-12-10Election of the following nominees as directors: Frederic V. SalernoForWITHHOLD — 3 of 5 Equitable fundsForElected, 79.6% support
Madison Square Garden Entertainment Corp.2025-12-10Election of the following nominees as directors: Martin BandierForWITHHOLD — 3 of 5 Equitable fundsForElected, 79.4% support
AvePoint, Inc.2026-05-05Election of Directors: Brian Michael BrownForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 91.6% support
AvePoint, Inc.2026-05-05Election of Directors: Jeff EpsteinForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 76.8% support
AvePoint, Inc.2026-05-05Election of Directors: John HoForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 94.9% support
Cal-Maine Foods, Inc.2025-10-03Election of Class I Directors: Camille S. YoungForWITHHOLD — 3 of 5 Equitable fundsFor—
Shake Shack Inc.2026-06-10Election of Directors- Terms expiring at the 2029 Annual Meeting of Stockholders: Tristan WalkerForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 74.9% support
Century Aluminum Company2026-06-15Election of Directors: Andrew MichelmoreForWITHHOLD — 3 of 5 Equitable fundsForElected, 91.8% support
Century Aluminum Company2026-06-15Election of Directors: Errol GlasserForWITHHOLD — 3 of 5 Equitable fundsForElected, 89.0% support
Century Aluminum Company2026-06-15Election of Directors: Jarl BerntzenForWITHHOLD — 3 of 5 Equitable fundsForElected, 91.4% support
Century Aluminum Company2026-06-15Election of Directors: Jennifer BushForWITHHOLD — 3 of 5 Equitable fundsForElected, 91.6% support
Century Aluminum Company2026-06-15Election of Directors: Tamla OlivierForWITHHOLD — 3 of 5 Equitable fundsForElected, 91.6% support
Century Aluminum Company2026-06-15Election of Directors: Wilhelm van JaarsveldForWITHHOLD — 3 of 5 Equitable fundsForElected, 99.2% support
ADMA Biologics, Inc.2026-06-02To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Alison C. FingerForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 89.0% support
ADMA Biologics, Inc.2026-06-02To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eduardo Rene SalasForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 97.6% support
Vertex, Inc.2026-06-10Election of directors: David DeStefanoForWITHHOLD — 3 of 5 Equitable fundsForElected, 99.6% support
Vertex, Inc.2026-06-10Election of directors: Eric AndersenForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.2% support
Upstart Holdings, Inc.2026-05-28Election of Directors: Ciaran O'KellyForWITHHOLD — 3 of 5 Equitable fundsForElected, 86.9% support
Upstart Holdings, Inc.2026-05-28Election of Directors: Kerry CooperForWITHHOLD — 3 of 5 Equitable fundsForElected, 97.5% support
Upstart Holdings, Inc.2026-05-28Election of Directors: Mary HentgesForWITHHOLD — 3 of 5 Equitable fundsForElected, 98.4% support
Recursion Pharmaceuticals, Inc.2026-06-17Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement.ForAGAINST — 3 of 5 Equitable fundsForApproved, 87.0% support
Recursion Pharmaceuticals, Inc.2026-06-17Election of Directors: Franziska Michor, Ph.D.ForWITHHOLD — 3 of 5 Equitable fundsForElected, 87.3% support
Astrana Health, Inc.2026-06-10To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: David G. SchmidtForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 93.7% support
Harmony Biosciences Holdings, Inc.2026-05-14Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules.ForAGAINST — 3 of 5 Equitable fundsForApproved, 71.8% support
Harmony Biosciences Holdings, Inc.2026-05-14The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Ron PhilipForWITHHOLD — 3 of 5 Equitable fundsForElected, 68.5% support
Harmony Biosciences Holdings, Inc.2026-05-14The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy IgnelziWithholdFOR — 3 of 5 Equitable fundsAgainstElected, 70.6% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: David HodgsonForWITHHOLD — 3 of 5 Equitable fundsForElected, 60.8% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jacqueline KosecoffForWITHHOLD — 3 of 5 Equitable fundsForElected, 76.1% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jody BilneyForWITHHOLD — 3 of 5 Equitable fundsForElected, 76.1% support
NovoCure Limited2026-06-03The approval of our amended and restated 2024 Omnibus Incentive Plan.ForAGAINST — 3 of 5 Equitable fundsForApproved, 50.3% support
UMH Properties, Inc.2026-05-27Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Angela D. Pruitt-MarriottForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 96.2% support
UMH Properties, Inc.2026-05-27Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Jeffrey A. CarusForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 95.2% support
UMH Properties, Inc.2026-05-27Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Kenneth K. Quigley, Jr.ForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 96.0% support
UMH Properties, Inc.2026-05-27Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Matthew I. HirschForWITHHOLD — 3 of 5 Equitable fundsForPassed (calculated), 59.1% support
Quantum Computing Inc.2026-06-24Elect six directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: Dr. Carl WeimerWithholdFOR — 3 of 5 Equitable fundsAgainstElected, 82.9% support
Quantum Computing Inc.2026-06-24Elect six directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: Robert FagensonWithholdFOR — 3 of 5 Equitable fundsAgainstElected, 90.6% support
Coursera, Inc.2026-06-10The election of three Class II directors to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Andrew Y. NgForWITHHOLD — 3 of 5 Equitable fundsForElected, 86.1% support
Coursera, Inc.2026-06-10The election of three Class II directors to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Christopher D. McCarthyForWITHHOLD — 3 of 5 Equitable fundsForElected, 84.4% support
Eos Energy Enterprises, Inc.2026-06-03Amendment to our Second Amended and Restated 2020 Incentive Plan.ForAGAINST — 3 of 5 Equitable fundsForApproved, 74.8% support
Eos Energy Enterprises, Inc.2026-06-03Election of Directors: Claude DembyForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 76.7% support
Eos Energy Enterprises, Inc.2026-06-03Non-binding advisory vote to approve our named executive officer compensation.ForAGAINST — 3 of 5 Equitable fundsForApproved, 75.3% support
eXp World Holdings, Inc.2026-05-08Election of Directors to serve for a one-year term expiring in 2027. Randall MilesAgainstFOR — 3 of 5 Equitable fundsAgainstPassed (calculated), 88.9% support
Cogent Communications Holdings, Inc.2026-05-01To hold an advisory vote to approve named executive officer compensation.ForAGAINST — 3 of 5 Equitable fundsFor—
Jamf Holding Corp.2026-01-08A proposal to adopt the Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement"), dated as of October 28, 2025, by and among Jamf, Jawbreaker Parent, Inc., a Delaware corporation ("Parent"), and Jawbreaker Merger Sub, Inc., a DForABSTAIN — 3 of 5 Equitable fundsForApproved, 99.8% support
LiveRamp Holdings, Inc.2025-08-12Election of Directors: Brian O'KelleyForAGAINST — 3 of 5 Equitable fundsForElected, 95.6% support
LiveRamp Holdings, Inc.2025-08-12Election of Directors: Clark M. KokichForAGAINST — 3 of 5 Equitable fundsForElected, 92.3% support
Moog Inc.2026-02-10Election of directors: Class A Director - Term Expiring 2029: Brenda ReichelderferForWITHHOLD — 3 of 5 Equitable fundsForElected, 95.0% support
StoneCo Ltd.2026-04-23Accept Financial Statements and Statutory ReportsAbstainFOR — 3 of 5 Equitable fundsAgainst—
StoneCo Ltd.2026-04-23Elect Director Antonio SilveiraForAGAINST — 3 of 5 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Diego Fresco GutierrezForAGAINST — 3 of 5 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Gilberto CaldartForAGAINST — 3 of 5 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Jose Alexandre ScheinkmanForAGAINST — 3 of 5 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Luciana Ibiapina Lira AguiarForAGAINST — 3 of 5 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Luis Henrique Cals de Beauclair GuimaraesForAGAINST — 3 of 5 Equitable fundsFor—
StoneCo Ltd.2026-04-23Elect Director Mauricio Luis LuchettiForAGAINST — 3 of 5 Equitable fundsFor—

Download all 208 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 89.7% of this fund’s 8,596 such votes could be given a sector; the other 882 (10.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care1,905160.8%
Consumer Discretionary1,40480.6%
Finance1,20420.2%
Technology1,09550.5%
Industrials92030.3%
Energy26000.0%
Real Estate23400.0%
Miscellaneous16900.0%
Utilities16900.0%
Basic Materials12300.0%
Consumer Staples11832.5%
Telecommunications11310.9%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5,69916
Audit-related1,0650
Say-on-Pay1,0374
Compensation3711
Corporate Governance2639
Capital Structure1514
Extraordinary Transactions1000
Shareholder Rights and Defenses241
Other100
Diversity, Equity, and Inclusion22

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
agilon health, inc.March 17, 2026$383M20
Cloudflare, Inc.June 30, 2026$24M140
agilon health, inc.June 2, 2026$15M51
HealthEquity, Inc.June 25, 2026$12M140
GRAIL, Inc.June 18, 2026$12M30
Appian CorporationJune 3, 2026$11M122
Bloom Energy CorporationMay 21, 2026$5M80
Etsy, Inc.June 9, 2026$5M71

Notable votes against management

MeetingCompanyProposalFundMgmt
June 2, 2026agilon health, inc.Election of Class II Directors: Ronald WilliamsForAgainst
June 3, 2026Appian CorporationElection of Directors: Barbara Bobbie KilbergForAgainst
June 3, 2026Appian CorporationTo approve the Appian Corporation Amended and Restated 2017 Equity Incentive Plan.ForAgainst
June 9, 2026Etsy, Inc.Advisory vote on a stockholder proposal to govern by majority vote. Shareholder proposalAgainstFor
April 28, 2026The Brink's CompanyAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
May 20, 2026Lumen Technologies, Inc.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalAgainstFor
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalAgainstFor
June 3, 2026Power Integrations, Inc.To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposalAgainstFor
May 7, 2026Wolverine World Wide, Inc.Shareholder proposal regarding new climate change polices or practices. Shareholder proposalAgainstFor
May 14, 2026Calix, Inc.To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposalForAgainst
July 11, 2025Brookdale Senior Living Inc.Election of Directors: Ortelius Nominees OPPOSED by the Company: Steven J. Insoft Shareholder proposalWithholdFor

Contested meetings

Meetings with a proxy contest or competing nominees (8 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

8,726 ballot items at 1,177 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, EQ/Morgan Stanley Small Cap Growth Portfolio voted at 1,177 shareholder meetings of 1,109 companies, on 8,726 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 39 times. Its most frequent area of disagreement was director elections (16 of its votes against management). It voted on 29 shareholder proposals. It voted FOR the board's own proposals more often than Equitable's funds as a whole (94.5% against 92.5%). It voted differently from most Equitable funds on 208 items. 8 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.